Cargando…
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098641/ https://www.ncbi.nlm.nih.gov/pubmed/33953192 http://dx.doi.org/10.1038/s41467-021-23082-3 |
| _version_ | 1783688450879258624 |
|---|---|
| author | Iketani, Sho Forouhar, Farhad Liu, Hengrui Hong, Seo Jung Lin, Fang-Yu Nair, Manoj S. Zask, Arie Huang, Yaoxing Xing, Li Stockwell, Brent R. Chavez, Alejandro Ho, David D. |
| author_facet | Iketani, Sho Forouhar, Farhad Liu, Hengrui Hong, Seo Jung Lin, Fang-Yu Nair, Manoj S. Zask, Arie Huang, Yaoxing Xing, Li Stockwell, Brent R. Chavez, Alejandro Ho, David D. |
| author_sort | Iketani, Sho |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8098641 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80986412021-05-06 Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors Iketani, Sho Forouhar, Farhad Liu, Hengrui Hong, Seo Jung Lin, Fang-Yu Nair, Manoj S. Zask, Arie Huang, Yaoxing Xing, Li Stockwell, Brent R. Chavez, Alejandro Ho, David D. Nat Commun Author Correction Nature Publishing Group UK 2021-05-05 /pmc/articles/PMC8098641/ /pubmed/33953192 http://dx.doi.org/10.1038/s41467-021-23082-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Iketani, Sho Forouhar, Farhad Liu, Hengrui Hong, Seo Jung Lin, Fang-Yu Nair, Manoj S. Zask, Arie Huang, Yaoxing Xing, Li Stockwell, Brent R. Chavez, Alejandro Ho, David D. Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors |
| title | Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors |
| title_full | Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors |
| title_fullStr | Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors |
| title_full_unstemmed | Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors |
| title_short | Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors |
| title_sort | author correction: lead compounds for the development of sars-cov-2 3cl protease inhibitors |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098641/ https://www.ncbi.nlm.nih.gov/pubmed/33953192 http://dx.doi.org/10.1038/s41467-021-23082-3 |
| work_keys_str_mv | AT iketanisho authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT forouharfarhad authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT liuhengrui authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT hongseojung authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT linfangyu authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT nairmanojs authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT zaskarie authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT huangyaoxing authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT xingli authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT stockwellbrentr authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT chavezalejandro authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT hodavidd authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors |